H. Richards

发表

Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer’s disease: post-hoc analysis of a randomized placebo-controlled study

M. Sano, H. Brashear, John Han, 2016, Alzheimer's Research & Therapy.

A phase I, pharmacokinetic, and biological study of the farnesyltransferase inhibitor tipifarnib in combination with gemcitabine in patients with advanced malignancies.

C. Takimoto, A. Patnaik, E. Rowinsky, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer.

F. Khuri, H. Safran, B. Johnson, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Safety and efficacy of once-daily hydromorphone extended-release versus twice-daily oxycodone hydrochloride controlled-release in chinese patients with cancer pain: a phase 3, randomized, double-blind, multicenter study.

Shiying Yu, John Han, W. Shen, 2014, The journal of pain : official journal of the American Pain Society.

Single‐ and multiple‐dose pharmacokinetic studies of tramadol immediate‐release tablets in children and adolescents

A. van Peer, H. Richards, J. Vandenbossche, 2015, Clinical pharmacology in drug development.

Safety, Tolerability, and Pharmacokinetics of Therapeutic and Supratherapeutic Doses of Tramadol Hydrochloride in Healthy Adults: A Randomized, Double‐Blind, Placebo‐Controlled Multiple‐Ascending‐Dose Study

J. Natarajan, Thomas Murtaugh, Binu Alexander, 2017, Clinical pharmacology in drug development.

Single‐Dose Pharmacokinetic Study of Tramadol Extended‐Release Tablets in Children and Adolescents

A. Peer, H. Richards, J. Vandenbossche, 2016, Clinical pharmacology in drug development.

The effect of UGT2B7*2 polymorphism on the pharmacokinetics of OROS® hydromorphone in Taiwanese subjects

A. van den Bergh, Chih-Cherng Lu, H. Richards, 2014, Journal of clinical pharmacology.

Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study

D. Fife, A. Sena, P. Hu, 2018, PLoS ONE.

Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS® hydromorphone ER) in patients with chronic pain

U. Richarz, H. Richards, J. Vandenbossche, 2012, Journal of pain research.

Bioequivalence and safety of a novel fentanyl transdermal matrix system compared with a transdermal reservoir system.

J. Natarajan, H. Richards, K. Moore, 2018, Journal of opioid management.

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease

M. Sano, H. Brashear, John Han, 2014, Neuropsychiatric disease and treatment.

Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer’s disease: post-hoc analysis of a randomized placebo-controlled study

M. Sano, H. Brashear, John Han, 2016, Alzheimer's Research & Therapy.